Ironwood Pharmaceuticals (IRWD) Finished Goods (2017 - 2019)

Ironwood Pharmaceuticals (IRWD) posted Finished Goods of $191000.0 for Q4 2019, down 58.21% sequentially from $457000.0 in Q3 2019.

Ironwood Pharmaceuticals (IRWD) Finished Goods (2017 - 2019) Analysis & Trends

Ironwood Pharmaceuticals has reported Finished Goods for 3 years, with the latest figure at $191000.0 in Q4 2019.

Quarterly Finished Goods changed N/A year-over-year to $191000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $191000.0 (changed N/A YoY) and the FY2019 annual result came in at $191000.0, changed N/A from the prior year.
Finished Goods eased to $191000.0 in Q4 2019 per IRWD's latest filing, from $457000.0 in the prior quarter.
Over five years, Finished Goods peaked at $1.4 million in Q1 2018 and troughed at $76000.0 in Q3 2018.
A 3-year average of $589428.6 and a median of $479000.0 in 2017 frame the typical range for Finished Goods.
The sharpest annual moves came in 2018 and 2019: Finished Goods slumped 84.13% in 2018, then surged 501.32% in 2019.
Over 3 years, Finished Goods stood at $735000.0 in 2017, then plunged by 89.66% to $76000.0 in 2018, then soared by 151.32% to $191000.0 in 2019.
According to Business Quant data, Finished Goods over the past three periods registered $191000.0, $457000.0, and $76000.0 for Q4 2019, Q3 2019, and Q3 2018 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-
10	Ironwood Pharmaceuticals	676.53 Mn	597.40 Mn	-

Download Data